| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 31, 2024 | Jun 3, 2024 | aTYR PHARMA INC | CEO | Buy | 91.3 | +20,000 | 17.16% | ✗ | $36.1K |
| Dec 11, 2023 | Dec 12, 2023 | aTYR PHARMA INC | CEO | Buy | 91.3 | +15,000 | 16.45% | ✗ | $17.6K |
| Nov 10, 2023 | Nov 13, 2023 | aTYR PHARMA INC | CEO | Buy | 91.3 | +15,000 | 19.69% | ✗ | $16.7K |
| Jul 28, 2023 | Aug 1, 2023 | aTYR PHARMA INC | CEO | Buy | 91.3 | +15,000 | 24.52% | ✗ | $30.2K |
| Nov 21, 2022 | Nov 21, 2022 | aTYR PHARMA INC | CEO | Buy | 91.3 | +10,000 | 24.51% | ✗ | $21.4K |
| Jul 1, 2022 | Jul 6, 2022 | aTYR PHARMA INC | CEO | Buy | 91.3 | +15,000 | 58.14% | ✗ | $43.2K |
| Jan 7, 2022 | Jan 10, 2022 | aTYR PHARMA INC | CEO | Buy | 91.3 | +5,000 | 24.04% | ✗ | $33.8K |
| Nov 15, 2021 | Nov 15, 2021 | aTYR PHARMA INC | CEO | Buy | 91.3 | +2,500 | 13.66% | ✗ | $21.4K |
| May 18, 2021 | May 20, 2021 | aTYR PHARMA INC | CEO | Buy | 91.3 | +10,000 | 120.51% | ✗ | $40.1K |
| Feb 6, 2021 | Feb 9, 2021 | aTYR PHARMA INC | CEO | Sell | 47.5 | -778 | -8.57% | ✗ | $6K |
| Jun 19, 2020 | Jun 23, 2020 | aTYR PHARMA INC | CEO | Buy | 91.3 | +6,000 | 464.76% | ✗ | $25.6K |
| Feb 6, 2020 | Feb 7, 2020 | aTYR PHARMA INC | CEO | Sell | 47.5 | -745 | -36.59% | ✗ | $3K |